Study Stopped
Poor compliance with returning of logbooks by families. Two patients were enrolled. Only one returned the logbook and therefore not analyzed
The Effects of Reducing Stomach Acid on Post-tonsillectomy Pain
The Effects of Gastro-esophageal Acid Suppression on Post-tonsillectomy Pain
1 other identifier
interventional
2
1 country
2
Brief Summary
This study was designed to determine whether post-operative pain following a tonsillectomy can be reduced by adding an antacid-like medication to the medications taken after surgery. It is hypothesized that even a small amount of stomach acid backing up and entering the mouth can increase post-tonsillectomy pain. Therefore, the use of an antacid-like medication should help to decrease pain and reduce the amount of narcotic medication required for pain control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Jun 2008
Typical duration for phase_4
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 10, 2007
CompletedFirst Posted
Study publicly available on registry
May 11, 2007
CompletedStudy Start
First participant enrolled
June 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2011
CompletedResults Posted
Study results publicly available
December 6, 2021
CompletedDecember 6, 2021
November 1, 2021
2.7 years
May 10, 2007
November 3, 2021
November 3, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The Primary Outcome is the Number of Days to Become Free of Narcotic Pain Medication.
2 weeks
Secondary Outcomes (1)
The Secondary Outcomes Are the Number of Days to be Free of Pain, the Number of Days to Return to Normal Activity Levels and the Number of Days to Return to Normal Fluid Intake.
2 weeks
Study Arms (2)
1
EXPERIMENTALPost-operative administration of Lansoprazole
2
PLACEBO COMPARATORPlacebo
Interventions
If weight is less than 30 kg, 15 mg of Lansoprazole twice daily will be administered. If weight is greater than or equal to 30 kg, 30 mg of Lansoprazole twice daily will be administered.
Eligibility Criteria
You may qualify if:
- All healthy children ages 5-18 years scheduled for tonsillectomy and /or adenotonsillectomy for sleep disturbance secondary to airway obstruction at Children's Hospital Boston
You may not qualify if:
- Patients on any medications other than the study drug (Lansoprazole or placebo), Amoxicillin®, and acetaminophen with or without codeine
- An underlying medical condition which would necessitate an alteration in the anesthetic regimen
- Patients allergic to any of the medications in the protocol
- History of chronic tonsillitis
- History of chronic pain conditions
- History of active gastro-esophageal reflux disease
- Surgery in addition to tonsillectomy/adenotonsillectomy (except for myringotomy)
- Cognitive/developmental disorders
- Inability to use a self-report pain scale
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Children's Hospital Boston
Boston, Massachusetts, 02115, United States
Childrens Hospital Boston
Boston, Massachusetts, 02115, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Manali Amin, MD
- Organization
- Dupage Chidlren's ENT & Allergy
Study Officials
- PRINCIPAL INVESTIGATOR
Manali Amin, MD
Children's Hosptial Boston
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Instructor
Study Record Dates
First Submitted
May 10, 2007
First Posted
May 11, 2007
Study Start
June 1, 2008
Primary Completion
February 1, 2011
Study Completion
February 1, 2011
Last Updated
December 6, 2021
Results First Posted
December 6, 2021
Record last verified: 2021-11